Evidence map›Paper›PMID 36684675›Full record

ArticlePeerJ2023

Differential expression of lysine acetylation proteins in gastric cancer treated with a new antitumor agent bioactive peptide chelate selenium.

Yanan Xu, Jianxun Wen, Wenyan Han, Jin Yan, Wei Jia, Xiulan Su

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Adaptation of White Adipocytes to Cooler Temperatures: Impacts on Energy Metabolism and Protein Acetylation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yanan Xu *Clinical Medical Research Center, Inner Mongolia Bioactive Peptide Engineering Laboratory, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Jianxun Wen *College of Basic Medicine, Inner Mongolia Medical University, Hohhot, China.
Wenyan HanClinical Laboratory, The Second Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Jin YanClinical Medical Research Center, Inner Mongolia Bioactive Peptide Engineering Laboratory, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Wei JiaClinical Medical Research Center, Inner Mongolia Bioactive Peptide Engineering Laboratory, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Xiulan SuClinical Medical Research Center, Inner Mongolia Bioactive Peptide Engineering Laboratory, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Inner Mongolia Medical University · CNSecond Affiliated Hospital of Inner Mongolia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The method of anticancer bioactive peptide (ACBP) functionalized selenium particle (Se), which has enhanced anticancer activity, inhibited the growth of gastric cancer (GC) cells, and increased the ability of apoptosis

Indexed as

Antineoplastic AgentsSeleniumStomach NeoplasmsAcetylationHumansLysinePeptidesProteomeAntineoplastic AgentsLysinePeptidesProteomeSeleniumAcetylationAnticancer bioactive peptidesGastric cancerSelenium

Identifiers

PMID36684675
PMCPMC9854375
OpenAlexW4316690009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.